Advisory Services Network, LLC Bicycle Therapeutics PLC Transaction History

Advisory Services Network, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$13.29 - $22.2 $1,528 - $2,553	115 New	115 $2,000
Q4 2022 Feb 13, 2023	BUY	$20.37 - $32.9 $2,342 - $3,783	115 New	115 $3,000
Q3 2021 Nov 05, 2021	SELL	$27.95 - $44.24 $2,795 - $4,424	-100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$27.0 - $32.28 $2,700 - $3,228	100 New	100 $3,000
Q1 2021 May 24, 2021	SELL	$19.12 - $30.25 $1,912 - $3,025	-100 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$15.3 - $20.8 $1,530 - $2,080	100 New	100 $2,000

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $581M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.